Zimmer Biomet
914 hedge funds and large institutions have $17.4B invested in Zimmer Biomet in 2026 Q1 according to their latest regulatory filings, with 95 funds opening new positions, 313 increasing their positions, 302 reducing their positions, and 107 closing their positions.
400% more funds holding in top 10
Funds holding in top 10: 2 → 10 (+8)
4% more repeat investments, than reductions
Existing positions increased: 313 | Existing positions reduced: 302
3% less capital invested
Capital invested by funds: $17.9B → $17.4B (-$492M)
1.86% less ownership
Funds ownership: 100.18% → 98.32% (-1.9%)
3% less funds holding
Funds holding: 946 → 914 (-32)
11% less first-time investments, than exits
New positions opened: 95 | Existing positions closed: 107
12% less call options, than puts
Call options by funds: $27.1M | Put options by funds: $30.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$183M |
| 2 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$98M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$96.4M |
| 4 |
Harris Associates
Chicago,
Illinois
|
+$63.8M |
| 5 |
Holocene Advisors
New York
|
+$54.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$517M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$203M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$123M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$113M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$87.4M |
ZBH Hedge Fund Activity: Q1 2026 in Review
914 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q1 2026, worth a combined $17.4B — down 2.8% from $17.9B a quarter earlier.
Sellers outnumbered buyers: 107 funds closed out of ZBH and 95 opened new positions — a net loss of 12 holders — while 302 trimmed existing stakes and 313 added.
The largest buyer was Capital International Investors, adding an estimated $183M. The largest seller was T. Rowe Price Associates, cutting an estimated $517M.
- 914 institutional investors held Zimmer Biomet (ZBH) as of Q1 2026, down from 946 in Q4 2025.
- Funds reported $17.4B of Zimmer Biomet stock for Q1 2026, down 2.8% quarter-over-quarter.
- 95 funds opened new Zimmer Biomet positions in Q1 2026 and 107 closed out, a net change of -12 holders.
- The largest Zimmer Biomet buyer in Q1 2026 was Capital International Investors, an estimated $183M added.
- The largest Zimmer Biomet seller in Q1 2026 was T. Rowe Price Associates, an estimated $517M sold.
Based on aggregated 13F filings for Q1 2026.